Heparin Binding Protein

Heparin Binding Protein from Axis Shield

Heparin Binding Protein
  • AXIS-SHIELD
  • HOMOCYSTEINE
  • ACTIVE B12
Skip to content
  • Home
  • Sepsis
  • What is HBP?
  • Clinical Utility
  • Measuring HBP
  • Publications
  • Exhibitions
  • Contact Us
  • Video
  • For every hour that proper treatment is delayed the mortality associated with severe sepsis increases by 7 percent.
  • Severe sepsis is the leading cause of death in the non-coronary ICU with mortality rates between 30-50 percent.
  • In the US, sepsis is regarded as the 10th leading cause of death, higher than breast, colorectal, prostate and pancreatic cancers
  • For every hour that proper treatment is delayed the mortality associated with severe sepsis increases by 7 percent.
  • Severe sepsis is the leading cause of death in the non-coronary ICU with mortality rates between 30-50 percent.
  • In the US, sepsis is regarded as the 10th leading cause of death, higher than breast, colorectal, prostate and pancreatic cancers
  • For every hour that proper treatment is delayed the mortality associated with severe sepsis increases by 7 percent.
  • Severe sepsis is the leading cause of death in the non-coronary ICU with mortality rates between 30-50 percent.
Title

Contact Us

Axis-Shield Diagnostics Ltd.

Luna Place
The Technology Park
Dundee DD2 1XA
Scotland

T: +44 (0)1382 422000
F: +44 (0)1382 422088
E: AXD.heparinbindingprotein@alere.com

Registered in Scotland: 77359

Terms & Conditions: www.alere.com/en/home/policies.html
Privacy Policy: www.alere.com/en/home/privacy.html
 LinkedIn

Axis Shield at a Glance

A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories.

Axis Shield